ArticleNature metabolism2024
Author Correction: ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response.
Abstract readPublished Erratum
In one paragraph
Article in Nature metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- PUF, a biflavone monomer, triggers DNA damage through SLC25A15 downregulation and purine metabolic suppression in DLBCL.Journal of translational medicine · 2026Article
- Multi-target synergistic anti-aging: QG extends Caenorhabditis elegans lifespan through DAF-16/FOXO pathways, mitochondrial homeostasis and metabolic reprogramming.Biogerontology · 2025Article
- Acute Alkaline Stress Activates Glucose Metabolism for Energy Supply and Induces the Immune Response in the Oriental River Prawn, Macrobrachium nipponense.Marine biotechnology (New York, N.Y.) · 2025Article
- Adaptation to Arginine Deprivation Leads to a More Aggressive, Therapy-Resistant Phenotype in HNSCC Cells.Biomolecules · 2025Article
- ASS1: Guardian of the genome.Nature reviews. Cancer · 2024Article
Corrections and comments
- Erratum for
Authors and funding
29 authors.
Lisha Qiu Jin Lim *Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-4023-4456
Lital Adler *Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0001-8805-2216
Emma HajajDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0003-2437-3146
Leandro R SoriaTelethon Institute of Genetics and Medicine, Pozzuoli, Italy.ORCID http://orcid.org/0000-0002-7124-856X
Rotem Ben-Tov PerryDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0003-0745-231X
Naama DarziDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Ruchama BrodyDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Noa FurthDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0001-8728-519X
Michal LichtensteinDepartment of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Elizabeta Bab-DinitzDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Ziv PoratDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0003-3059-181X
Tevie MelmanDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Alexander BrandisDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Sergey MalitskyDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Maxim ItkinDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Yael AylonDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Shifra Ben-DorDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0001-9604-1939
Irit OrrDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Amir Pri-OrThe De Botton Protein Profiling Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel.
Rony SegerDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
Yoav ShaulDepartment of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Eytan RuppinCancer Data Science Lab, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-7862-3940
Moshe OrenDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0003-4311-7172
Minervo PerezCancer Data Science Lab, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.
Jordan MeierCancer Data Science Lab, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.
Nicola Brunetti-PierriTelethon Institute of Genetics and Medicine, Pozzuoli, Italy.ORCID http://orcid.org/0000-0002-6895-8819
Efrat ShemaDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
Igor UlitskyDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0003-0555-6561
Ayelet ErezDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. ayelet.erez@weizmann.ac.il.ORCID http://orcid.org/0000-0002-9696-0393
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.